The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| GDTC | -36.08% | N/A | N/A | -62% |
| S&P | +15.66% | +86.6% | +13.29% | +67% |
CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
No news articles found for CytoMed Therapeutics.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
